Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: Results from the phase III, placebo-controlled QUAZAR AML-001 trial

  1. Roboz, G.J.
  2. Döhner, H.
  3. Pocock, C.
  4. Dombret, H.
  5. Ravandi, F.
  6. Jang, J.H.
  7. Selleslag, D.
  8. Mayer, J.
  9. Martens, U.M.
  10. Liesveld, J.
  11. Bernal, T.
  12. Wang, M.C.
  13. Yu, P.
  14. Shi, L.
  15. Guo, S.
  16. Torre, I.L.
  17. Skikne, B.
  18. Dong, Q.
  19. Braverman, J.
  20. Nehme, S.A.
  21. Beach, C.L.
  22. Wei, A.H.
Aldizkaria:
Haematologica

ISSN: 1592-8721,  0390-6078

Argitalpen urtea: 2021

Alea: 106

Zenbakia: 12

Orrialdeak: 3240-3244

Mota: Gutuna

DOI: 10.3324/HAEMATOL.2021.279174 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus